CoChat

Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy

Open access

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

Next-Generation Gene Therapy: Few disciplines in contemporary clinical research have experienced the high expectations directed at the gene therapy field. However, gene therapy has been challenging to translate to the clinic, often because the therapeutic gene is expressed at insufficient levels in the patient or because the gene delivery vector integrates near protooncogenes, which can cause leukemia (see the Perspective by Verma ). Biffi et al. ( 1233158 , published online 11 July) and Aiuti et al. ( 1233151 ; published online 11 July) report progress on both fronts in gene therapy trials of three patients with metachromatic leukodystrophy (MLD), a neurodegenerative disorder, and three patients with Wiskott-Aldrich syndrome (WAS), an immunodeficiency disorder. Optimized lentiviral vectors were used to introduce functional MLD or WAS genes into the patients' hematopoietic stem cells (HSCs) ex vivo, and the transduced cells were then infused back into the patients, who were then monitored for up to 2 years. In both trials, the patients showed stable engraftment of the transduced HSC and high expression levels of functional MLD or WAS genes. Encouragingly, there was no evidence of lentiviral vector integration near proto-oncogenes, and the gene therapy treatment halted disease progression in most patients. A longer follow-up period will be needed to further validate efficacy and safety.

Overview

Integrity signals

Registry

Crossref · 10.1126/science.1233158

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. 10.1002/(SICI)1098-1004(1997)9:3<234::AID-HUMU4>3.0.CO;2-7 · doi:10.1002/(sici)1098-1004(1997)9:3<234::aid-humu4>3.0.co;2-7

Cited by

See all 1,180

Metadata

Authors
Biffi, A., Montini, E., Lorioli, L., Cesani, M., Fumagalli, F., Plati, T., Baldoli, C., Martino, S., Calabria, A., Canale, S., Benedicenti, F., Vallanti, G., Biasco, L., Leo, S., Kabbara, N., Zanetti, G., Rizzo, W. B., Mehta, N. A. L., Cicalese, M. P., Casiraghi, M., Boelens, J. J., Del Carro, U., Dow, D. J., Schmidt, M., Assanelli, A., Neduva, V., Di Serio, C., Stupka, E., Gardner, J., von Kalle, C., Bordignon, C., Ciceri, F., Rovelli, A., Roncarolo, M. G., Aiuti, A., Sessa, M., & Naldini, L.
Affiliations
  • IRCCS Ospedale San Raffaele (IT)
  • The San Raffaele Telethon Institute for Gene Therapy (IT)
  • Vita-Salute San Raffaele University (IT)
  • University of Perugia (IT)
  • MolMed (Italy) (IT)
  • Center for Advanced Studies Research and Development in Sardinia (IT)
  • Rafik Hariri University Hospital (LB)
  • University of Nebraska Medical Center (US)
  • GlaxoSmithKline (United Kingdom) (GB)
  • University Medical Center Utrecht (NL)
  • Neurology Unit, Department of Neurology, San Raffaele Scientific Institute, 20132 Milan, Italy.
  • German Cancer Research Center (DE)
  • Vita-Salute San Raffaele University, 20132 Milan, Italy.
  • GlaxoSmithKline (United States) (US)
  • Department of Translational Oncology, National Center for Tumor Diseases and German Cancer Research Center, 69120 Heidelberg, Germany.
  • Azienda Ospedaliera San Gerardo (IT)
  • University of Rome Tor Vergata (IT)
Corresponding author
  • Biffi, Alessandra
  • Montini, Eugenio
  • Naldini, Luigi
Venue
Science
Published
2013-08-23
Volume
341
Issue
6148
Pages
1233158-1233158
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W2089319449
Cited by
1,180
References
62
Citations by year
2026: 28 · 2025: 42 · 2024: 64 · 2023: 62 · 2022: 60 · 2021: 74 · 2020: 92 · 2019: 101 · 2018: 98 · 2017: 109 · 2016: 133 · 2015: 147 · 2014: 133 · 2013: 31
FWCI
97.94
Type
journal article
Language
en
Licence
other-oa
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
  • INFM-OAR (INFN Catania) (submittedVersion, other-oa)
  • Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
  • Health Sciences › Medicine › Oncology › CAR-T cell therapy research
Keywords
metachromatic leukodystrophy, Wiskott-Aldrich syndrome, lentiviral vectors, hematopoietic stem cell gene therapy, ex vivo gene transfer, leukemia risk, HSC engraftment, neurodegenerative diseases, immunodeficiency, disease progression
MeSH terms
Brain, Cerebroside-Sulfatase, DNA Damage, Follow-Up Studies, Genetic Engineering, Genetic Vectors, Hematopoietic Stem Cells, Humans, Leukodystrophy, Metachromatic, Magnetic Resonance Imaging, Transduction, Genetic, Genetic Therapy, Lentivirus, Virus Integration, Treatment Outcome, Hematopoietic Stem Cell Transplantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.